Comprehensive longitudinal characterization of canine muscular dystrophy by serial NMR imaging of GRMD dogs

Neuromuscular Disorders

Volumn 22, Issue SUPPL. 2, 2012, Pages

  Thibaud, J L ^a,b   Azzabou, N ^b,c,d   Barthelemy, I ^a   Fleury, S ^b,c,d   Cabrol, L ^b,c,d   Blot, S ^a   Carlier, P G ^b,c,d  

^a ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^b Institute of Myology   (France)

^c DIF   (France)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

Contrast agent; Dog; GRMD; Imaging; Muscular dystrophy; NMR; T1

Indexed keywords

GADOLINIUM CHELATE; GADOLINIUM PENTETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL MUSCULAR DYSTROPHY; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DOG; IMAGE ANALYSIS; LONGITUDINAL STUDY; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PELVIS RADIOGRAPHY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SIGNAL NOISE RATIO; THORAX RADIOGRAPHY;

ANIMALS; DOGS; IMAGE PROCESSING, COMPUTER-ASSISTED; LONGITUDINAL STUDIES; MAGNETIC RESONANCE SPECTROSCOPY; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL;

EID: 84866269578     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2012.05.010     Document Type: Article

References (30)

1. Sampaolesi M., Blot S., D'Antona G., et al. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 2006, 444:574-579.
2. Wang Z., Chamberlain J.S., Tapscott S.J., Storb R. Gene therapy in large animal models of muscular dystrophy. ILAR J 2009, 50:187-198.
3. Lu Q.-L., Yokota T., Takeda Si., Garcia L., Muntoni F., Partridge T. The status of exon skipping as a therapeutic approach to Duchenne muscular dystrophy. Mol Ther 2011, 19:9-15.
4. American Thoracic Society ATS Statement: Guidelines for the Six-Minute Walk Test. Am J Respirat, Crit Care Med 2002;166:111-117.
5. Boddy K.N., Roche B.M., Schwartz D.S., Nakayama T., Hamlin R.L. Evaluation of the six-minute walk test in dogs. Am J Vet Res 2004, 65:311-313.
6. Barthélémy I., Barrey E., Thibaud J.-L., et al. Gait analysis using accelerometry in dystrophin-deficient dogs. Neuromuscul Disord 2009, 19:788-796.
7. Barthélémy I., Barrey E., Aguilar P., et al. Longitudinal ambulatory measurements of gait abnormality in dystrophin-deficient dogs. BMC Musculoskeletal Disord 2011, 12:75.
8. Tardif-de Gery S., Vilquin J., Carlier P., et al. Muscular transverse relaxation time measurement by magnetic resonance imaging at 4 Tesla in normal and dystrophic dy/dy and dy(2j)/dy(2j) mice. Neuromuscul Disord 2000, 10:507-513.
9. Walter G., Cordier L., Bloy D., Sweeney H.L. Noninvasive monitoring of gene correction in dystrophic muscle. Magn Resonan Med 2005, 54:1369-1376.
10. Straub V., Donahue K.M., Allamand V., Davisson R.L., Kim Y.R., Campbell K.P. Contrast agent-enhanced magnetic resonance imaging of skeletal muscle damage in animal models of muscular dystrophy. Magn Reson Med 2000, 44:655-659.
11. Amthor H., Egelhof T., McKinnell I., et al. Albumin targeting of damaged muscle fibres in the mdx mouse can be monitored by MRI. Neuromuscul Disord 2004, 14:791-796.
12. Willmann R., Possekel S., Dubach-Powell J., Meier T., Ruegg Ma. Mammalian animal models for Duchenne muscular dystrophy. Neuromuscul Disord 2009, 19:241-249.
13. Thibaud J.L., Monnet A., Bertoldi D., Barthélémy I., Blot S., Carlier P.G. Characterization of dystrophic muscle in Golden Retriever Muscular Dystrophy dogs by nuclear magnetic resonance imaging. Neuromuscul Disord 2007, 17:575-584.
14. Barthélémy I., Thibaud J.L., Vulin A., et al. Functional evaluation of dystrophic dogs treated by exon-skipping. Neuromuscul Disord 2007, 17:898.
15. Yokota T., Lu Q.-L., Partridge T. Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs. Ann Neurol 2009, 65:667-676.
16. Bartlett R.J., Winand N.J., Secore S.L., et al. Mutation segregation and rapid carrier detection of X-linked muscular dystrophy in dogs. Am J Vet Res 1996, 57:650-654.
17. Savitzky A., Golay M.J.E. Smoothing and differentiation of data by simplified least squares procedures. Anal Chemistry 1964, 36:1627-1639.
18. Le Guiner C., Montus M., Servais L., et al. The AFMsDc. Effective limb transduction and phenotypic correction after injection of rAAV8-U7 snRNA in GRMD dogs. Mol Ther 2011, 19:S29.
19. Degardin A., Morillon D., Lacour A., Cotten A., Vermersch P., Stojkovic T. Morphologic imaging in muscular dystrophies and inflammatory myopathies. Skeletal Radiol 2010, 39:1219-1227.
20. Kobayashi M., Nakamura A., Hasegawa D., Fujita M., Orima H. Takeda Si. Evaluation of dystrophic dog pathology by fat-suppressed T2-weighted imaging. Muscle Nerve 2009, 40:815-826.
21. Chang D.C., Misra L.K., Beall P.T., Fanguy R.C., Hazlewood C.F. Nuclear magnetic resonance study of muscle water protons in muscular dystrophy of chickens. J Cell Physiol 1981, 107:139-145.
22. Misra L.K., Luthra M.G., Amtey S.R., Elizondo-Riojas G., Swezey S.H., Todd L.E. Enhanced T1 differentiation between normal and dystrophic muscles. Magn Reson Imaging 1984, 2:33-35.
23. Matsumura K., Nakano I., Fukuda N., Ikehira H., Tateno Y., Aoki Y. Proton spin-lattice relaxation time of Duchenne dystrophy skeletal muscle by magnetic resonance imaging. Muscle Nerve 1988, 11:97-102.
24. Liu G.-C., Jong Y.-J., Chiang C.-H., Jaw T.-S. Duchenne muscular Dystrophy: MR grading system with functional correlation. Radiology 1993, 186:475-480.
25. Garrood P., Hollingsworth K.G., Eagle M., et al. MR imaging in Duchenne muscular dystrophy: quantification of T1-weighted signal, contrast uptake, and the effects of exercise. J Magn Reson Imaging 2009, 30:1130-1138.
26. Freeman R. A handbook of nuclear magnetic resonance 1988, Longman Scientific and Technical and Wiley and Sons, Essex.
27. Boulby P.A., Rugg-Gunn F. T2: the transverse relaxation time. Quantitative MRI of the brain measuring changes caused by diseases 2003, 143-202. Wiley and Sons, Chichester.
28. Kornegay J.N., Tuler S.M., Miller D.M., Levesque D.C. Muscular dystrophy in a litter of golden retriever dogs. Muscle Nerve 1988, 11:1056-1064.
29. Wren T.A., Bluml S., Tseng-Ong L., Gilsanz V. Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. AJR Am J Roentgenol 2008, 190:W8-12.
30. Tyler D.J., Robson M.D., Henkelman R.M., Young I.R., Bydder G.M. Magnetic resonance imaging with ultrashort TE (UTE) PULSE sequences: technical considerations. J Magn Reson Imaging 2007, 25:279-289.